Inflammasomes and Cell Death: Common Pathways in Microparticle Diseases

被引:38
作者
Rashidi, Maryam [1 ,2 ]
Wicks, Ian P. [1 ,2 ]
Vince, James E. [1 ,2 ]
机构
[1] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
atherosclerosis; inflammasome; necroptosis; neuroinflammation; NLRP3; pyroptosis;
D O I
10.1016/j.molmed.2020.06.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The accumulation of cellular and environmental microparticles has been linked to many diseases associated with tissue inflammation. These particulate-driven diseases include joint, lung, kidney, cardiovascular, and neurodegenerative disorders. Recently a conserved proinflammatory inflammasome signaling pathway elicited by such microparticles has become apparent. Here, we review disease promoting microparticles and the mechanisms by which they trigger activation of the inflammasome complexes responsible for generating bioactive interleukin1 beta (IL-1 beta) and inducing cell death. We highlight how microparticle-induced inflammasome and cell death responses diverge from canonical inflammasome activators, and discuss the preclinical and clinical targeting of inflammasomes to treat microparticle-driven diseases.
引用
收藏
页码:1003 / 1020
页数:18
相关论文
共 50 条
  • [31] Inflammasomes and their roles in autoimmune diseases
    Pan, Minghui
    Yang, Jie
    Jiang, Zhengfan
    RHEUMATOLOGY & AUTOIMMUNITY, 2024, 4 (04): : 197 - 217
  • [32] Different types of cell death in vascular diseases
    Saberianpour, Shirin
    Karimi, Abbas
    modaghegh, Mohammad Hadi Saeed
    Ahmadi, Mahdi
    MOLECULAR BIOLOGY REPORTS, 2021, 48 (05) : 4687 - 4702
  • [33] Targeting inflammasomes in rheumatic diseases
    So, Alexander
    Ives, Annette
    Joosten, Leo A. B.
    Busso, Nathalie
    NATURE REVIEWS RHEUMATOLOGY, 2013, 9 (07) : 391 - 399
  • [34] Inflammasomes in neurological diseases: emerging pathogenic and therapeutic concepts
    Mamik, Manmeet K.
    Power, Christopher
    BRAIN, 2017, 140 : 2273 - 2285
  • [35] Cell Death Pathways in Ischemic Stroke and Targeted Pharmacotherapy
    Aishika Datta
    Deepaneeta Sarmah
    Leela Mounica
    Harpreet Kaur
    Radhika Kesharwani
    Geetesh Verma
    Pabbala Veeresh
    Vignesh Kotian
    Kiran Kalia
    Anupom Borah
    Xin Wang
    Kunjan R. Dave
    Dileep R. Yavagal
    Pallab Bhattacharya
    Translational Stroke Research, 2020, 11 : 1185 - 1202
  • [36] Cell Death Pathways in Ischemic Stroke and Targeted Pharmacotherapy
    Datta, Aishika
    Sarmah, Deepaneeta
    Mounica, Leela
    Kaur, Harpreet
    Kesharwani, Radhika
    Verma, Geetesh
    Veeresh, Pabbala
    Kotian, Vignesh
    Kalia, Kiran
    Borah, Anupom
    Wang, Xin
    Dave, Kunjan R.
    Yavagal, Dileep R.
    Bhattacharya, Pallab
    TRANSLATIONAL STROKE RESEARCH, 2020, 11 (06) : 1185 - 1202
  • [37] Stress/cell death pathways, neuroinflammation, and neuropathic pain
    Li, Lu
    Li, Tian
    Qu, Xinyu
    Sun, Guangwei
    Fu, Qi
    Han, Guang
    IMMUNOLOGICAL REVIEWS, 2024, 321 (01) : 33 - 51
  • [38] The Multifaceted Roles of Pyroptotic Cell Death Pathways in Cancer
    Wang, Man
    Jiang, Shuai
    Zhang, Yinfeng
    Li, Peifeng
    Wang, Kun
    CANCERS, 2019, 11 (09)
  • [39] Regulated Cell Death Pathways in Pathological Cardiac Hypertrophy
    Wu, Shengnan
    Ding, Ding
    Wang, Deguo
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2024, 25 (10)
  • [40] Intracellular Staphylococcus aureus and host cell death pathways
    Soe, Ye Mon
    Bedoui, Sammy
    Stinear, Timothy P.
    Hachani, Abderrahman
    CELLULAR MICROBIOLOGY, 2021, 23 (05)